China News
-
111 Partners with Tong Ren Tang Technologies to Advance "Internet + Healthcare"
China | News | 0 Comment | 14 Jun, 2019
111, Inc., a leading integrated online and offline healthcare platform, on 13 June 2019, announced that it has signed a strategic partnership agreement with Tong Ren Tang Technologies Co., ...Read more
-
First Uzbekistani Company in Hong Kong to bring Chinese Medicine Business along "The Belt and Road"
China | News | 0 Comment | 14 Jun, 2019
"The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held in Hong Kong on 13 June 2019, by Yulin Bagu Group JV LLC. The event wa...Read more
-
China NMPA Approves Sinovant's Clinical Trial Application for Lefamulin
China | News | 0 Comment | 14 Jun, 2019
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted by the Center for Drug Evaluation at the China National Medical Produc...Read more
-
Terns Pharmaceuticals and Shanghai Tuosheng Biotechnology initiate TERN-101 first phase trial
China | News | 0 Comment | 14 Jun, 2019
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch of a clinical FXR agonist of TERN-101 Phase I trials to further supp...Read more
-
Inaugural Global Health Forum of Boao Forum for Asia held in China
China | News | 0 Comment | 14 Jun, 2019
The inaugural Global Health Forum (GHF) of Boao Forum for Asia (BFA) was held in Qingdao, China, from June 10 to June 12. Aimed at gathering global consensus on healthc...Read more
-
Parexel teams up with CLARINESS for enhanced patient engagement in China
China | News | 0 Comment | 13 Jun, 2019
Parexel, a leader in the development of innovative new therapies to improve the world’s health has announced a strategic partnership with CLARINESS, a leading global patient recruitme...Read more
-
China Aged Care Market focuses on Medical-Nursing Combined Care
China | News | 0 Comment | 12 Jun, 2019
The "China Aged Care Industry Report, 2019-2025" report has been added to ResearchAndMarkets.com's offering. China's society has aged before it gets rich. By the end of...Read more
-
GT Healthcare Capital Partners launches AI-driven drug development company
China | News | 0 Comment | 14 Jun, 2019
GT Healthcare Capital Partners, a life science-focused private equity partnership which specializes in capital investments and market scalability in Asia/ Greater China region, has launched...Read more
-
Deciphera Pharma, Zai Lab to bring anti-cancer drug in Greater China
China | News | 0 Comment | 13 Jun, 2019
Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, and Zai Lab Ltd, a China and U.S.-based i...Read more
-
Calliditas Therapeutics to commercialize autoimmune drug in China, Singapore
China | News | 0 Comment | 11 Jun, 2019
Sweden based Calliditas Therapeutics AB (“Calliditas”) and US based Everest Medicines II Limited (“Everest Medicines”) announced that they have entered into a licens...Read more
-
Ping An Good Doctor launches groundbreaking service
China | News | 0 Comment | 10 Jun, 2019
China based Ping An Healthcare and Technology Company Limited, the world's leading one-stop healthcare ecosystem platform, has launched the innovative "Private Doctor" service in the Ping A...Read more
-
CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
China | News | 0 Comment | 10 Jun, 2019
CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Bayer HealthCare LLC to evaluate the safety, tolerability, pharmacokineti...Read more
-
Ascentage Pharma presents new clinical data of apoptosis targeted drug candidates
China | News | 0 Comment | 07 Jun, 2019
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases has announced that t...Read more
-
BioMarin receives approval for rare syndrome treatment in China
China | News | 0 Comment | 07 Jun, 2019
US based BioMarin Pharmaceutical Inc. has announced that Vimizim® (elosulfase alfa) has been approved by the National Medical Products Administration (NMPA) for the treatment of patient...Read more
-
China | News | 0 Comment | 06 Jun, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company, presented the research data on the treatment of relapsed or refractory extranodal NK/T cell lymphoma (ORIENT-4) by sintili...Read more
-
Global Cord Blood Corp receives non-binding proposal letter from Cordlife Group
China | News | 0 Comment | 06 Jun, 2019
Global Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today anno...Read more
-
CStone to initiate clinical development of CS1001 and BLU-554 in combination therapy for HCC
China | News | 0 Comment | 06 Jun, 2019
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in China of CS1001 in combination with BLU-554 (CS3008) in patients ...Read more
-
China | News | 0 Comment | 06 Jun, 2019
RemeGen, Ltd. announced positive promising results for a Phase II clinical trial of RC48 on 4 June 2019, in Yantai, China. Results, presented at the 2019 American Society of Clinical O...Read more
